Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Gastric Function Using Body Surface Gastric Mapping in Patients on Semaglutide (Ozempic)

NCT06401746 is registered in ClinicalTrials.gov with University of Western Sydney as lead sponsor.

NCT NCT06401746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06401746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Gastric Function Using Body Surface Gastric Mapping in Patients on Semaglutide (Ozempic)
Lead sponsor
University of Western Sydney
Phase
Observational
Overall status
Completed
Start date
May 1, 2024
Completion date
June 1, 2025
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis, semaglutide-induced gastric motility